Biocon to Produce Devices for Insulin Portfolio
Biocon opens a facility to manufacture devices for its insulin portfolio. The facility is said to be spread over 10,000 […]
Say something
Tags: Biocon, biology, diabetes, Diabetes mellitus type 1, Eli Lilly and Company, Endocrine system, Health/Medical/Pharmaceuticals, healthcare, India, insulin, Insulin glargine, insulin products, insulin-dependent diabetes, Kiran Mazumdar-Shaw, media reports, medicine, pen like delivery devices, Peptide hormones, Recombinant proteins
-
-
Flipkart Health+ App Launched
06-04-2022
